Mar 26th, 2015

Are Biotech Stocks Overvalued and in a Bubble?

Clearbridge Investments Health Care Analyst Marshall Gordon discusses the performance of biotech stocks. Bloomberg’s Drew Armstrong also speaks on “Market Makers.”” (Source: Bloomberg)